Developments in the field of biotechnology have been categorized into three ‘waves’ or stages. In the first stage or the ‘green wave’, the industry was dominated by the agricultural applications of biotechnology. This was followed by medical applicat ....see more
The neuromodulation market is expected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% during the forecast period. The major players operating in this market are Medtronic (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), and LivaNova (UK).
The cell therapy technologies market is expected to grow from USD 4.0 billion in 2022 to USD 8.0 billion by 2027, at a CAGR of 14.6% during the forecast period. Key players in the Market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Manufacturing Corporation (US).
The gene therapy market is expected to grow from USD 7.3 billion in 2022 to USD 17.2 billion by 2027, at a CAGR of 18.6% during the forecast period. Key players in the gene therapy market include Biogen (US), Novartis AG (Switzerland), Gilead Sciences Inc. (US), and Sarepta Therapeutics (US)
The global efficacy testing market is projected to reach USD 423 million by 2027, at a CAGR of 6.1% during the forecast period. The prominent players in this market are Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK).
The epigenetics market is expected to grow from USD 1.7 billion in 2022 to USD 3.9 billion by 2027, at a CAGR of 18.1% during the forecast period. The epigenetics market is moderately consolidated with prominent players operating in this market such as Thermo Fisher Scientific (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US), Bio-Rad Laboratories (US), Promega Corporation (US), PerkinElmer (US), Qiagen (Germany), New England Biolabs (US), Zymo Research Corporation (US), Diagenode (Germany), and F. Hoffmann-La Roche Ltd (Switzerland).
The global 3D Bioprinting Market is expected to grow from USD 1.3 billion in 2022 to USD 3.3 billion by 2027, at a compound annual growth rate (CAGR) of 20.8% during the forecast period.The Key players BICO Group AB (US), Organovo Holdings Inc. (US), Allevi, Inc. (part of 3D Systems, Inc.) (US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), EnvisionTEC GmbH (part of Desktop Metal, Inc.) (Germany), Aspect Biosystems Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), and Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China).
The research antibodies & reagents market is expected to grow from USD 11.6 billion in 2022 to USD 16.1 Billion by 2027, at a CAGR of 6.7% during the forecast period. The prominent market players are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).
The global stem cell assays market is expected to grow from USD 1.9 billion in 2022 to USD 4.5 billion by 2027, at a compound annual growth rate (CAGR) of 17.7 % during the forecast period.The key players Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), PerkinElmer (US), Agilent Technologies (US), Promega Corporation (US), Cell Biolabs (US), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Bio-Techne Corporation (US), FUJIFILM Holdings Corporation (Japan), Charles River Laboratories (US), HemoGenix Inc. (US), Lonza Group (Switzerland), Takara Bio Inc. (Japan), Creative Bioarray (US), AAT Bioquest, Inc. (US), BPS Bioscience, Inc. (US), Enzo Biochem (US), PromoCell GmbH (Germany), Biotium (US), Geno Technology (US), Abcam plc (UK), and ReachBio Research Labs (US).
The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025, at a CAGR of 8.9% during the forecast period. QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation and purification market. Other prominent players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
The in vitro toxicology testing market is projected to reach USD 18.6 billion by 2027, at a CAGR of 10.8% during the forecast period. The prominent players in the in vitro toxicology testing market include Thermo fisher Scientific, Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).
The global cell analysis market is projected to reach USD 28.6 billion by 2027, at a CAGR of 10.1% during the forecast period. The cell analysis market is fragmented in nature with prominent players operating in this market such as Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
3D Cell Culture Market is expected to grow from USD 1.3 billion in 2022 to USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. Key players in the 3D Cell Culture market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), Avantor Inc. (US), Tecan Trading AG (Switzerland), REPROCELL Inc. (Japan), 3D Biotek LLC. (US), Emulate Inc. (US), CN Bio Innovations (UK), Synthecon Incorporated (US), and InSphero AG (Switzerland).
The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027, at a CAGR of 6.7% during the forecast period. The plasma fractionation market is an oligopolistic market. The prominent players operating in this market include CSL (Australia), Grifols, S.A. (Spain), Shire (US), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), LFB (France), Biotest AG (Germany), Sanquin (Netherlands), China Biologic Products Holdings Inc. (China), GC Pharma (Korea), Bio Products Ltd. (UK), Japan Blood Products Organization (Japan), Emergent BioSolutions (US), Shanghai Raas Blood Products Co., Ltd. (China), Intas Pharmaceuticals Ltd. (India), Bharat Serum Vaccines Limited (India).
The tangential flow filtration market is projected to reach USD 2.8 billion by 2027, at a CAGR of 13.2% during the forecast period. Key players in the Market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker Hannifin Corporation (US), Repligen Corporation (US), Alfa Laval Corporate AB (Sweden), ANDRITZ (Austria), Meissner Filtration Products, Inc. (US), Cole-Parmer Instrument Company, LLC (US), Solaris Biotechnology Srl (Italy), Koch Separation Solutions (US), Sterlitech Corporation US), Synder Filtration, Inc. (US), PendoTECH (US), ARTeSYN Biosolutions (Ireland), Microfilt India Pvt. Ltd. (India), Bionet (Spain), SYSBIOTECH GmbH (Austria), Cobetter Filtration Equipment Co., Ltd. (China), Biotree (India), FORMULATRIX (US), Mantec Technical Ceramics Ltd. (UK), Smartflow Technologies (US), TAMI Industries (France), and SPF Technologies LLC (US).
The human microbiome market is expected to grow from USD 269 million in 2023 to USD 1,370 million by 2029, at a compound annual growth rate (CAGR) of 31.1% during the forecast period.The major players Enterome Bioscience (France), Seres Therapeutics (US) 4D Pharma (UK), and Ferring Pharmaceuticals (Switzerland).
The metagenomic sequencing market is expected to grow from USD 1.9 billion in 2022 to USD 4.3 billion by 2027, at a compound annual growth rate (CAGR) of 18.4% during the forecast period.The leading players Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK).
The exosome research market is expected to grow from USD 144 million in 2021 to USD 661 million by 2026, at a CAGR of 35.6% during the forecast period. Prominent players in the global exosome research market are Thermo Fisher Scientific (US), System Biosciences (US), Bio-Techne (US), Lonza (Switzerland), QIAGEN N.V. (Germany), NX PharmaGen (US), Miltenyi Biotec (US), AMS Biotechnology (US), NanoSomiX (US), Norgen Biotek Corp. (US), Novus Biologicals (US), BioVision Inc. (US), Pall Corporation (US), Exopharm Limited (Australia), and EverZom (France).
The global Pharmaceutical Filtration market is projected to reach USD 29.7 billion by 2027, at a CAGR of 17.0% during the forecast period. Key players in the Pharmaceutical Filtration Market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US).
The cell culture media market is expected to grow from USD 4.9 billion in 2021 to USD 10.3 billion by 2026, at a CAGR of 16.0% during the forecast period. Key players in the cell culture media market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany), Corning Incorporated (US).
The global cell culture market is expected to grow from USD 22.8 billion in 2021 to USD 41.3 billion by 2026, at a compound annual growth rate (CAGR) of 12.6 % during the forecast period.The key players Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany).
The global peptide synthesis market is expected to grow from USD 515 million in 2021 to USD 730 million by 2026, at a compound annual growth rate (CAGR) of 7.2 % during the forecast period.The key players Thermo Fisher Scientific (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
The virology specimen collection Market is expected to grow from USD 5.6 billion in 2021 to USD 5.4 billion by 2026, at a CAGR of -0.6% during the forecast period. The major players operating in this market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).
The global genome editing/genome engineering market is expected to grow from USD 5.1 billion in 2021 to USD USD 11.7 billion by 2026, at a compound annual growth rate (CAGR) of 18.2 % during the forecast period.The Key players Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and GenScript (China).
The global western blotting market is projected to reach USD 1.4 billion by 2026, at a CAGR of 6.7% during the forecast period. Some of the leading players operating in the western blotting market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany).
The global immunohistochemistry market is expected to grow from USD 2.3 billion in 2021 to USD 3.3 billion by 2026, at a compound annual growth rate (CAGR) of 7.7% during the forecast period.The Prominent players in the F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US).
The global laboratory filtration market is projected to reach USD 5.3 billion by 2026, at a CAGR of 7.8% during the forecast period. The prominent players in the market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), 3M Company (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Steris (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc. (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc. (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc. (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).
The Aptamers Market is expected to grow from USD 151 million in 2021 to USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Some of the prominent players operating in this market include Aptamer Group (UK), Raptamer Discovery Group (US), SomaLogic Inc. (US), Aptamer Sciences, Inc. (South Korea) and Aptagen, LLC (US).
The animal growth promoters and performance enhancers market industry is projected to grow from USD 16.2 billion in 2021 and to reach USD 21.4 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. Prominent players in the Animal Growth Promoters and Performance Enhancers Market include are Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd. (South Africa) and Novus International, Inc. (US).
The flow cytometry market is porjected to reach USD 6.3 billion in 2026, at CAGR of 8.1% during the forecast period. The prominent players in the flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted both organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the flow cytometry market.
The bioprocess containers market is expected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a compound annual growth rate (CAGR) of 26.3% during the forecast period.Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany)
The protein characterization and identification market is projected to reach USD 23.9 billion by 2026, at a CAGR of 13.7% during the forecast period. Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) are the prominent players operating in the protein characterization and identification market.
The global single-cell analysis market is projected to reach USD 6.3 billion by 2026, at a CAGR of 15.1% during the forecast period. The prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Illumina, Inc. (US), Fluidigm Corporation (US), 10X Genomics (US), and Corning Incorporated (US).
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026, at a CAGR of 21.1% during the forecast period. The prominent players operating in the single-use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).
The Single use Bioprocessing Market is expected to grow from USD 8.2 billion in 2021 to USD 20.8 billion by 2026, at a CAGR of 20.5% during the forecast period. The single-use bioprocessing market is highly consolidated with majority of the market share taken up by key players such as Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.
The Biomarkers Market is expected to grow from USD 43.1 billion in 2021 to USD 78.1 billion in 2026, at a CAGR of 12.6% during the forecast period. Some of the leading players operating in the biomarkers market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Enzo Biochem, Inc. (US), Charles River Laboratories International, Inc. (US), and Eurofins Scientific (Luxembourg).
The Cell & Gene Therapy Manufacturing Services marke is expected to grow from USD 7.7 billion in 2021 to USD 13.8 billion by 2026, at a compound annual growth rate (CAGR) of 12.4% during the forecast period.Thermo Fisher Scientific (US), Merck KGaA (Germany), Charles River Laboratories (US), Lonza (Switzerland), Catalent (US), WuXi AppTec (China), Takara Bio Inc. (Japan), Nikon Corporation (Japan), FUJIFILM Holdings Corporation (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), Oxford Biomedica plc (UK), and Cell and Gene Therapy Catapult (UK).
The Collagen & Gelatin Market is expected to grow from USD 772 million in 2021 to USD 1,083 million by 2026, at a CAGR of 7.0% during the forecast period. Key players in the collagen and gelatin markets include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).
The Hollow Fiber Filtration Market is expected to grow from USD 303 million in 2021 to USD 597 million by 2026, at a CAGR of 14.5% during the forecast period. Prominent players in the hollow fiber filtration market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market.
The global animal genetics market is projected to reach USD 7.7 billion by 2026, at a CAGR of 7.1% during the forecast period. The major players in the global animal genetics market include Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding (Netherlands), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US), Hendix Genetics (Netherlands), Animal Genetics (US), VetGen (US), DanBred (Denmark), Tropical Bovine Genetics (India), Trans Ova Genetics (US), Inguran LLC dba ST Genetics (US), Semex Alliance (Canada), Genetic Veterinary Sciences (US), Cobb-Vantress (US), Milk Source (US), and Eurogene AI Services (Ireland).
The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026, at a CAGR of 14.2% during the forecast period. The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).
The Single-use Assemblies market is expected to grow from USD 2.2 billion in 2021 to USD 6.3 billion by 2026, at a compound annual growth rate (CAGR) of 23.3% during the forecast period.Thermo Fisher Scientific, Inc. (US), Sartorius Stedim Biotech (France), Danaher Corporation (US), Merck KGaA (Germany), Avantor, Inc. (US), and Saint-Gobain (France).
The synthetic biology market is expected to grow from USD 9.5 billion in 2021 to USD 30.7 billion by 2026, at a compound annual growth rate (CAGR) of 26.5% during the forecast period.Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).
The global stem cell manufacturing market is expected to grow from USD 11.5 billion in 2021 to USD 18.0 billion by 2026, at a compound annual growth rate (CAGR) of 9.4% during the forecast period.Thermo Fisher Scientific (US), Merck Milliopore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US) and Sartorius AG (Germany).
The global biologics safety testing market is expected to grow from USD 3.4 billion in 2021 to USD 6.2 billion by 2026, at a compound annual growth rate (CAGR) of 12.4% during the forecast period.Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg).
The global cell dissociation market is expected to grow from USD 282 million in 2021 to USD 561 million by 2026, at a compound annual growth rate (CAGR) of 14.7% during the forecast period.Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell GmbH (Germany) etc.
The global custom antibody market is expected to grow from USD 393 million in 2021 to USD 652 million by 2026, at a compound annual growth rate (CAGR) of 10.6% during the forecast period.Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US)
The global stem cell therapy market is expected to grow from USD 187 million in 2021 to USD 401 million by 2026, at a compound annual growth rate (CAGR) of 16.5% during the forecast period.Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).
The Next generation Sequencing Market is expected to grow USD 24.2 billion by 2026, growing at a CAGR of 18.7% during the forecast period. The prominent players operating in the NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), and Agilent Technologies (US).
The PDX model market is expected to grow from USD 140 million in 2021 to USD 299 million by 2026, at a compound annual growth rate (CAGR) of 16.4% during the forecast period.JSR Corporation (Japan), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), Oncodesign (France), Charles River Laboratories (US), Hera Biolabs (US), EPO Berlin-Buch (Germany), Envigo (US), Xentech (France), Urosphere (France), and Explora BioLabs (US).
The Oxidative Stress Assay Market is expected to grow from USD 836 million in 2020 to USD 1326 million by 2025, at a CAGR of 9.7% during the forecast period. Major players operating in the oxidative stress assay market include Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).